A potential strategy to control MAPK4-dependent cancer growth
This study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read MoreThis study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read MoreThe findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreCollaboration between bariatric surgery and and oncology teams identify patients with obesity who may be at a cancer risk.
Read MoreScientists evaluate therapy-dependent genomic changes in advanced cancer and the implications for cancer progression.
Read MoreThe findings suggest that therapies that interfere with MAPK6 activity may offer an effective cancer treatment approach.
Read MoreDr. Demetria Smith-Graziani discusses health disparities in breast cancer cases and shares information about screenings and treatment.
Read MoreThe bone microenvironment prompts changes in breast cancer cells that help them escape treatment and become more invasive.
Read MoreEsophageal cancer is one of the fastest-growing cancers in the United States and has been for the past 30-40 years, with cases increasing four-fold in
Read MoreAbout 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen
Read MoreWhen actress Angelina Jolie revealed that she was a carrier of a genetic mutation that increases her risk of developing breast cancer and ovarian cancer,
Read More